$28.22
-0.32-1.12%
Last update: Nov 10, 4:22 PM
Enovis Corp
ENOVNYSE
Enovis fell 9.4% from $31.51 to $28.54, behind the S&P 500's +9.8%. Its worst day was Sep 1 (−16.5%), and its low came Oct 8 at $17.43.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.95 beat the $0.83 estimate on $575.8M revenue (est. $583.0M); FY revenue guidance of $2.3B–$2.4B against the $2.4B consensus.
+13.9% · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
EPS of $0.89 beat the $0.81 estimate on $589.2M revenue (est. $571.6M); FY revenue guidance of $2.3B–$2.4B against the $2.3B consensus.
+9.7% · S&P 500 −0.3%
Enovis shares rose 15.1%, while the S&P 500 rose 0.9%.
+15.1% · S&P 500 +0.9%
EPS of $0.90 beat the $0.84 estimate on $582.8M revenue (est. $582.6M); FY revenue guidance of $2.3B–$2.4B against the $2.3B consensus.
−12.8% · S&P 500 −0.2%
Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room.
−16.5%, the year's worst day · S&P 500 −0.7%
Enovis closed at its lowest level of the year, 44.7% below where the year started.
−1.0% · S&P 500 −0.4%
EPS of $0.88 beat the $0.74 estimate on $558.7M revenue (est. $556.8M); FY revenue guidance of $2.3B–$2.4B against the $2.3B consensus.
+17.2%, the year's best day, on 6M shares, the year's heaviest volume · S&P 500 −4.4%
Where it ended: a close of $28.54 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $1.02, revenue est. $608.2M).
Nothing in the past 12 months.
All ENOV dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ENOV and SPY from Benzinga historical bars. Not investment advice.
